The Post-Covid Activist Puzzle

May 26, 2020 All Industries Activism

Activist investors have a large war chest that could see them going on a spending spree, as certain stocks remain highly deflated. How boards manage the Covid-19 response could determine whether they set their sights on the company.

The Coming Lawsuit Onslaught

April 29, 2020 All Industries Risk

As companies try to return to normal business, they will also have another concern to protect themselves from: Lawsuits. From healthcare, to cruise lines to insurance, most industries will have to deal with an onslaught of litigation from customers, partners and investors.

New Scrutiny Eyes Director Compensation

March 24, 2020 All Industries Compensation

For many years, director compensation was overshadowed by executive pay. But due to recent litigation, more shareholders and oversight organizations keep a close eye on the decisions made by your compensation committee. Without a clear pay growth strategy, then the company risks financial and public backlash.

How to Get a Healthcare Deal Done

February 18, 2020 Healthcare M&A

The healthcare industry has been a fountain of dealmaking lately. Companies wanting to make acquisitions or sell businesses this year should learn from the experts.

So Far, CAMs Reporting Reveals Little

January 21, 2020 All Industries Investors

A new disclosure requirement that’s described as the most significant change to the auditor’s report in 70 years is making a difference in the internal controls at large companies, although those looking for scandal so far have been disappointed.

How Not to Destroy a Deal

January 7, 2020 All Industries M&A

Kison Patel, the CEO of software company DealRoom, remembers working for a private equity firm trying to do a deal not long ago. His firm bombarded the target company with requests for information — including repetitive requests for the same information, often in Excel spreadsheets. Eventually, the seller got fed up and walked away.